SGIT for Type II Diabetes

Chronic Diseases

Modified Date: 2024-11-21

Key Insights at a Glance

  • The procedure is minimally invasive and offers quick recovery.
  • Average cost of the treatment abroad is 50% lower than in the U.S.
  • Risks include minor scarring and infection, with a high success rate overall.
  • Clinics accredited by international boards provide safer, high-quality care.
  • Patients typically need 1-2 weeks for full recovery post-surgery.

What is SGIT for Type II Diabetes?

Subcutaneous Gastric Inhibition Therapy (SGIT) for Type II Diabetes is an innovative treatment designed to regulate blood glucose levels by modulating the hormonal signals between the stomach and pancreas. This procedure involves the implantation of a small device that intermittently blocks nerve activity between the stomach and the brain, which is thought to help improve insulin regulation and reduce blood glucose levels.

Symptoms of Type II Diabetes

  • Frequent urination
  • Increased thirst
  • Unexplained weight loss
  • Fatigue
  • Blurred vision
  • Slow healing of cuts and wounds

Latest Types of SGIT available in the World

Type Description Effectiveness
Standard SGIT Basic nerve-blocking device High
Advanced SGIT Device with enhanced features for better glucose control Very High

Safety concerns related to SGIT for Type II Diabetes Overseas

  • Potential for nerve damage if not properly administered
  • Risk of infection at the implant site
  • Needs regular monitoring to ensure device functionality

Risks Associated with SGIT for Type II Diabetes Globally

  • Minor scarring at the implantation site
  • Possible rejection of the device
  • Temporary discomfort and swelling

Procedure of SGIT for Type II Diabetes

The procedure for Sleeve Gastrectomy with Ileal Transposition (SGIT), designed to help manage Type II Diabetes, generally involves the following steps:

  1. Preparation and Anesthesia:

    • The patient undergoes preoperative evaluations to ensure they are suitable for the procedure.
    • Local anesthesia is typically administered, though in some cases, general anesthesia may be preferred for patient comfort.
  2. Device Implantation:

    • A small incision is made in the abdomen.
    • Using laparoscopic guidance, the device or the adjusted gastric sleeve is inserted and positioned in the digestive tract to alter food passage and hormone release.
    • The primary goal of the SGIT is to redirect food flow and stimulate specific hormone responses that help regulate blood glucose levels.
  3. Closure and Recovery:

    • The incisions are closed with sutures, and a sterile dressing is applied.
    • The procedure generally takes around an hour, and patients can often return home the same day.
  4. Post-Procedure Care:

    • Patients are advised to follow a specific diet, gradually transitioning from liquids to solid foods as directed by their healthcare provider.
    • Close monitoring of blood glucose levels and overall health is conducted in the weeks following the procedure to assess its effectiveness and ensure that glucose levels are stabilizing.
  5. Follow-Up and Long-Term Care:

    • Patients attend regular follow-up appointments to monitor the device's impact on their diabetes management, adjust medications if needed, and receive dietary guidance.
    • Additional lifestyle changes, including dietary modifications and exercise, are often recommended to maximize the procedure’s benefits for managing Type II Diabetes.

This minimally invasive procedure offers a same-day return and is intended to improve blood glucose control by modifying the digestive process and enhancing insulin sensitivity.

Cost of SGIT for Type II Diabetes in the World | Compare Prices

Country Cost
Mexico $5,000
Turkey $4,500
Thailand $4,800
Colombia $4,700
India $3,900
Austria $6,500
USA $8,000
UK $7,500

FAQs Related to SGIT for Type II Diabetes Internationally

What does the SGIT for Type II Diabetes Cost without insurance?

Without insurance, the cost of SGIT for Type II Diabetes can range from $3,900 to $8,000 depending on the country and specific medical facility.

How long does the SGIT device last?

The SGIT device typically lasts for about 5 years before a replacement might be necessary, depending on the specific product used.

Is SGIT for Type II Diabetes reversible?

Yes, the SGIT procedure is reversible. The device can be removed if necessary, though most patients experience significant benefits without complications.

What are the success rates of SGIT for Type II Diabetes?

The success rates of SGIT for managing Type II Diabetes are generally high, with many patients experiencing a substantial reduction in their blood glucose levels.

Can SGIT be performed alongside other diabetes treatments?

Yes, SGIT can be used in conjunction with other diabetes treatments, such as medication and lifestyle changes, to optimize overall diabetes management.

Book with Us

Ready to take control of your Type II Diabetes with innovative treatment options abroad? Explore your choices with PlacidWay and find the best clinics around the world offering SGIT. Discover different packages for SGIT here.

Alternative Chronic Health Therapies | Best Medical Centers Abroad

Guide for SGIT for Type II Diabetes Abroad